Related Experiment Video
Updated: Feb 23, 2026

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
Published on: April 26, 2017
Dysregulation of spliceosome gene expression in advanced prostate cancer by RNA-binding protein PSF
Ken-Ichi Takayama1, Takashi Suzuki2, Tetsuya Fujimura3
1Department of Functional Biogerontology, Tokyo Metropolitan Institute of Gerontology, Tokyo 173-0015, Japan.
Abstract:
Developing therapeutic approaches are necessary for treating hormone-refractory prostate cancer. Activation of androgen receptor (AR) and its variants' expression along with the downstream signals are mostly important for disease progression. However, the mechanism for marked increases of AR signals and its expression is still unclear. Here, we revealed that various spliceosome genes are aberrantly induced by RNA-binding protein PSF, leading to enhancement of the splicing activities for AR expression. Our high-speed sequence analyses identified global PSF-binding transcripts. PSF was shown to stabilize and activate key long noncoding RNAs and AR-regulated gene expressions in prostate cancer cells. Interestingly, mRNAs of spliceosome-related genes are putative primary targets of PSF. Their gene expressions are up-regulated by PSF in hormone-refractory prostate cancer. Moreover, PSF coordinated these spliceosome proteins to form a complex to promote AR splicing and expression. Thus, targeting PSF and its related pathways implicates the therapeutic possibility for hormone-refractory prostate cancer.
Insights
Researchers discovered that the RNA-binding protein PSF enhances androgen receptor (AR) expression in hormone-refractory prostate cancer by inducing spliceosome genes. Targeting PSF offers a potential therapeutic strategy for this aggressive cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Hormone-refractory prostate cancer (HRPC) progression is driven by androgen receptor (AR) signaling.
- The precise mechanisms increasing AR signaling in HRPC remain incompletely understood.
- Developing novel therapeutic strategies for HRPC is a critical unmet need.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying enhanced AR expression in HRPC.
- To identify key regulators of AR splicing and expression in prostate cancer.
- To explore potential therapeutic targets for HRPC.
Main Methods:
- High-speed sequencing to identify global PSF-binding transcripts.
- Analysis of spliceosome gene induction and AR expression.
- Investigation of PSF's role in stabilizing noncoding RNAs and regulating gene expression in prostate cancer cells.
- Assessment of PSF-mediated spliceosome complex formation.
Main Results:
- Aberrant induction of spliceosome genes by RNA-binding protein PSF enhances AR splicing and expression in HRPC.
- PSF stabilizes key long noncoding RNAs and AR-regulated gene expression.
- Spliceosome-related gene mRNAs are primary targets of PSF, with their expression upregulated in HRPC.
- PSF forms complexes with spliceosome proteins to promote AR splicing and expression.
Conclusions:
- PSF plays a crucial role in driving AR signaling in hormone-refractory prostate cancer.
- Targeting PSF and its associated pathways presents a promising therapeutic avenue for HRPC.
- Understanding the PSF-spliceosome-AR axis is key to developing new treatments for advanced prostate cancer.
Related Concept Videos
RNA Splicing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alternative RNA Splicing
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
What is Gene Expression?
Regulation of Expression at Multiple Steps

